Resources

This document presents formative research results from PATH's HPV Vaccines: Evidence for Impact project in Vietnam. PATH is working with ministries of health and other country partners to develop strategies for introducing vaccines against human papillomavirus (HPV), the primary cause of cervical cancer.

This document presents formative research results from PATH's HPV Vaccines: Evidence for Impact project in India. PATH is working with ministries of health and other country partners to develop strategies for introducing vaccines against human papillomavirus (HPV), the primary cause of cervical cancer.

The MDR/XDR-TB Assessment and Monitoring Tool was designed to help national tuberculosis program staff, consultants, and donors conduct a baseline assessment for use in preparing a plan or funding application, monitoring progress, or identifying needs for technical assistance. It addresses two key questions: are there high-priority gaps in the DOTS program that must be corrected to prevent the development of cases of multidrug-resistant/extensively drug-resistant (MDR/XDR-TB), and what high-priority areas should be addressed to improve diagnosis and treatment of MDR/XDR-TB? The tool is available in English, Russian, and Spanish as a Microsoft Word file (for users who wish to modify it) and as an Adobe PDF file (recommended for printing). This 2009 tool informed the 2012 MDR-TB Planning Toolkit, which can be found here.

This report describes lessons learned and recommendations from regional advocacy, communication, and social mobilization (ACSM) workshops for Global Fund to Fight AIDS, Tuberculosis and Malaria recipient countries. The report describes the follow-on ACSM activities and outputs that have been generated at the country level as a result of participation in the workshops and makes recommendations for next steps in the development of effective ACSM interventions to support tuberculosis control goals and objectives.

From August 2004 to February 2005, the HIV prevention world was rocked by the suspension and cancellation of PrEP effectiveness trials in Cambodia and Cameroon. Acknowledging that no single version of the events constitutes the “real story,” the case studies in this document are built from extensive interviews with many stakeholders to reconstruct accounts of what eventually led to government intervention that halted the research. The case studies capture the political context and backdrop, the underlying and unaddressed conflicts that led to the costly collapse of two trials, and the lessons they provide for current and future research.